FDA Food Additives and GRAS Designation
The regulatory boundary between a food additive requiring formal premarket approval and a substance that qualifies as Generally Recognized as Safe (GRAS) determines how manufacturers bring ingredients and processing aids to market in the United States. This page covers the statutory definitions of food additives under the Federal Food, Drug, and Cosmetic Act (FD&C Act), the mechanics of the GRAS designation process, common scenarios where the distinction matters, and the decision boundaries that separate lawful use from regulatory violation. For a broader view of how this framework fits within FDA's overall mandate, see the FDA overview.
Definition and scope
Under 21 U.S.C. § 321(s), a food additive is any substance whose intended use results, or may reasonably be expected to result, directly or indirectly, in its becoming a component of food — unless that substance is generally recognized as safe among qualified scientific experts. This carve-out creates the GRAS exception: a substance that qualified experts — through scientific procedures, or through a history of safe use before January 1, 1958 — have determined to be safe under its conditions of intended use is exempt from the premarket approval requirement that otherwise applies to food additives.
The FDA's Center for Food Safety and Applied Nutrition (CFSAN) administers both pathways. The scope of regulated substances is broad: direct additives (intentionally introduced), indirect additives (migrating from packaging or processing equipment), and color additives (governed by a separate certification scheme under 21 U.S.C. § 379e) all fall within the framework.
Color additives are expressly excluded from the GRAS exemption by statute. That distinction is functionally significant — a manufacturer cannot invoke GRAS status for a synthetic colorant that requires batch certification under 21 C.F.R. Parts 73 and 74.
How it works
Premarket approval for food additives proceeds through a Food Additive Petition (FAP) submitted to FDA under 21 C.F.R. Part 171. The petition must include:
- Identity and composition of the substance
- Proposed conditions of use (food categories, maximum use levels)
- Safety data sufficient to establish a reasonable certainty of no harm under those conditions
- Proposed labeling or specifications
FDA then publishes a regulation in Title 21 of the Code of Federal Regulations authorizing the use if the petition is approved. This process can take multiple years from submission to final rule.
The GRAS pathway operates differently. A manufacturer may independently determine that a substance qualifies as GRAS — a self-determination requiring the same quality and quantity of scientific evidence that would support premarket approval, simply evaluated by qualified experts rather than FDA formally adjudicating the petition. Since 1997, FDA has operated a voluntary GRAS Notification Program (21 C.F.R. Part 269, proposed; administered under FDA's 2016 final rule at 81 Fed. Reg. 54960) through which manufacturers may notify FDA of a GRAS determination and receive a response letter — either a "no questions" letter, a letter noting that the notice does not establish GRAS status, or a cease-to-evaluate letter.
A critical structural fact: a manufacturer is not legally required to notify FDA before marketing a GRAS substance. The notification program is voluntary. However, an unnotified GRAS self-determination carries the full legal risk if FDA or a court later finds the safety basis insufficient.
Common scenarios
Scenario 1 — New functional ingredient. A company develops a novel enzyme for use in baking. Because the enzyme is not listed in an existing food additive regulation and has no pre-1958 history of safe use, it cannot rely on common-use GRAS. The company must either submit a Food Additive Petition or assemble a GRAS dossier supported by peer-reviewed toxicological and exposure data and submit a GRAS notification to FDA.
Scenario 2 — Established GRAS substance at a new use level. Salt (sodium chloride) is on FDA's list of substances affirmed as GRAS under 21 C.F.R. § 182.1. A manufacturer wishing to use salt at levels substantially above conventional food use in a new product category cannot automatically rely on the existing GRAS affirmation — conditions of use matter, and an extraordinary use level may require a new safety evaluation.
Scenario 3 — Indirect additive from packaging. A chemical migrating from a food-contact material into food is regulated as an indirect food additive. FDA's Food Contact Substance Notification (FCN) program under 21 U.S.C. § 348(h) provides a distinct premarket pathway for these substances, separate from the standard FAP process. An FCN becomes effective 120 days after FDA receipt unless FDA objects.
Decision boundaries
The choice between a Food Additive Petition, a GRAS notification, and a Food Contact Substance Notification is not discretionary in the sense that manufacturers may simply prefer one route. Statutory and regulatory criteria dictate which pathway applies:
| Factor | Food Additive Petition | GRAS Notification | FCN |
|---|---|---|---|
| Substance type | Direct or indirect, non-GRAS eligible | Direct or indirect, scientifically established safety | Food-contact material migrant |
| FDA action required before marketing | Yes — approved regulation must be in place | No — notification is voluntary | Yes — 120-day review window |
| Outcome | Published regulation in 21 C.F.R. | "No questions" letter or adverse response | Effective authorization or objection |
| Color additives covered? | Yes (separate Part 73/74 scheme) | No — excluded by statute | No |
Two boundaries are absolute. First, no substance may be marketed as a food additive without either an effective food additive regulation or a valid GRAS basis — doing so renders the food adulterated under 21 U.S.C. § 342(a)(2)(C), subject to FDA enforcement actions. Second, a GRAS self-determination is not a shield against FDA enforcement if the underlying science is inadequate — FDA retains authority to challenge the safety basis and initiate regulatory action under its inspection and enforcement authority.
The FDA Food Safety Modernization Act (FSMA), enacted in 2011, did not restructure the food additive or GRAS framework directly, but it expanded FDA's supply-chain oversight in ways that intersect with how foreign-sourced additives and food-contact materials enter the U.S. market. Manufacturers sourcing novel ingredients internationally must also evaluate import admissibility under FDA's import detention authority.
For the full regulatory context governing the substances covered on this page, the FDA food safety regulations framework and food labeling requirements are directly relevant — approved food additive uses must also comply with labeling disclosure rules under 21 C.F.R. Part 101.